Your session is about to expire
← Back to Search
Red Light Therapy for Peripheral Artery Disease
Study Summary
This trial is testing whether a single 5 minute exposure of 670 nm light can improve blood flow in people with peripheral artery disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a neurological condition like spinal stenosis or a pain disorder.I have been diagnosed with peripheral artery disease.I am younger than 18 or older than 85.I have high blood pressure in the lungs.Your blood pressure is higher than 160/95 and you are not receiving treatment for it.I have sickle cell disease.You are currently pregnant.You are currently using illegal drugs.You have a history of a hole in your heart.I am eligible regardless of my gender or ethnicity.You are allergic to perflutren contrast agents.I do not have any uncontrolled medical conditions.I am between 18 and 85 years old and have been diagnosed with peripheral artery disease.
- Group 1: Red Light treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals still being accepted to participate in this clinical trial?
"Per the listings on clinicaltrials.gov, this research project is still enrolling participants and has been since January 17th 2018. The entry was last modified on May 9th 2022."
Is this research open to elderly participants?
"The parameters for inclusion in this medical test state that applicants must be within the age range of 18 to 85. Separately, 13 trials are available specifically to minors while 247 clinical studies are tailored to those aged 65 and above."
Under what criteria are participants eligible to join this research?
"This research is actively seeking out 40 individuals, aged between 18 and 85, who are currently experiencing vasodilation. To be included in the study, patients must have been diagnosed with peripheral artery disease; recruitment will not discriminate on gender or ethnicity."
What is the total number of participants enrolled in this trial?
"Affirmative. Clinicaltrials.gov provides information that this medical trial, which was initially published on the 17th of January 2018, is presently recruiting volunteers. The research requires 40 patients to be drawn from a single center."
What is the predominant application of Red Light (670 nm energy)?
"Through the use of Red Light (670 nm energy), medical professionals can combat echocardiography, cardiovascular diseases, and diagnostic imaging."
Are there any other investigations which have utilized Red Light (670 nm energy)?
"At present, 19 investigations of Red Light (670 nm energy) are underway with one in its third phase. Most examinations take place within Philadelphia, Pennsylvania yet there are 26 other places where the research is being conducted."
Share this study with friends
Copy Link
Messenger